Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE is designed to discover selective oral small molecules to modulate protein-protein interactions as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17) that is a validated drug target implicated in a various immunology indications. It also develops DC-853, an oral IL-17 antagonist. In addition, the company is developing oral therapeutic candidates targeting alpha 4 beta 7 integrin for the treatment of inflammatory bowel diseases, as well as targeting alpha V beta 1/ alpha V beta 6 integrin for the treatment of idiopathic pulmonary fibrosis. Further, it focuses on programmed death-ligand 1 program, an immuno-oncology targeting antibody therapeutics. The company was founded in 2013 and is headquartered in South San Francisco, California. more
| Time Frame | DICE | S&P500 |
|---|---|---|
| 1-Week Return | - | 0.09% |
| 1-Month Return | - | -0.93% |
| 3-Month Return | - | 3.89% |
| 6-Month Return | - | 12.87% |
| 1-Year Return | - | 17.75% |
| 3-Year Return | - | 70.86% |
| 5-Year Return | -100% | 70.57% |
| Time Frame | DICE | S&P500 |
|---|---|---|
| 1-Week Return | 0.00% | 4.80% |
| 1-Month Return | 0.00% | -10.75% |
| 3-Month Return | 0.00% | 16.74% |
| 6-Month Return | 0.00% | 27.83% |
| 1-Year Return | 0.00% | 17.75% |
| 3-Year Return | 0.00% | 19.55% |
| 5-Year Return | -100.00% | 11.27% |
| Sector | Weight |
|---|---|
|
Health Care
|
100.00% |
Dice Molecules Holdings LLC (DICE) share price today is $25.1615.
Yes, Indians can buy shares of Dice Molecules Holdings LLC (DICE) on Vested. To buy DICE from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Dice Molecules Holdings LLC (DICE) on Vested. You can start investing in Dice Molecules Holdings LLC (DICE) with a minimum investment of $1.
The 52-week high price of Dice Molecules Holdings LLC (DICE) is $. The 52-week low price of Dice Molecules Holdings LLC (DICE) is $.
The stock symbol (or ticker) of Dice Molecules Holdings LLC is DICE.
Yes, you can setup SIP in Dice Molecules Holdings LLC shares. Follow the below steps to create the SIP:
Here is the historical performance of DICE on the Vested app.
The expense ratio of Dice Molecules Holdings LLC (DICE) is .
Link copied